StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.70−0.03 (-1.73%)

Close on Nov 18, 2026Market cap $4.75MP/E –Yield –

Processa Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Processa Pharmaceuticals's revenue for the twelve months ending Sep 30, 2023 was $0. For fiscal 2022 it was $0. The highest annual figure on record is $312.48K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$0–
FY2021Dec 31, 2021$0-100.0%
FY2016Dec 31, 2016$5.00K-95.6%
FY2015Dec 31, 2015$113.43K+5.8%
FY2014Dec 31, 2014$107.24K-65.7%
FY2013Dec 31, 2013$312.48K+62.6%
FY2012Dec 31, 2012$192.15K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0-100.0%
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–
Q2 FY2016Jun 30, 2016$0–
Q1 FY2016Mar 31, 2016$5.00K–

More Processa Pharmaceuticals figures

See a number that looks wrong?